Correlation Between Esperion Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Esperion Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Mersana Therapeutics.
Diversification Opportunities for Esperion Therapeutics and Mersana Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Esperion and Mersana is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.18 times less return on investment than Mersana Therapeutics. But when comparing it to its historical volatility, Esperion Therapeutics is 1.07 times less risky than Mersana Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Mersana Therapeutics on September 12, 2024 and sell it today you would earn a total of 71.00 from holding Mersana Therapeutics or generate 36.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| Esperion Therapeutics |
| Mersana Therapeutics |
Esperion Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite Esperion Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Esperion Therapeutics vs. Evoke Pharma | Esperion Therapeutics vs. Lantheus Holdings | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Ironwood Pharmaceuticals |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |